The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.
CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership.
Tinder, one of the most sought-after online dating platforms, enables many singles to match and chat by swiping right on their favorite profiles. The platform operates through a freemium model through ...
3D bio-printed liver model and high-content imaging for evaluating the toxicity effects of compounds
The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...
Researchers can now order their mutation of choice in bit.bio’s opti-ox TM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated ...
Primary human cells are considered the gold standard for advanced in vitro models; however, gut cells present challenges that limit their use. Altis’ RepliGut Planar model overcomes these limitations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback